SELECT
» Drugs in development
» Biotechnology facts and figures
» Key Technologies
DISEASES
» Anemia (2005)
» Breast Cancer (2007)
» Cardiovascular Diseases (2007)
» Diabetes (2005)
» Growth Hormone Deficiency (2005)
» Haemophilia (2005)
» Hepatitis B (2005)
» Inflammatory Bowel Disease (2007)
» Lymphomas (2005)
» Multiple Sclerosis (2005)
» Rheumatoid Arthritis and other Inflammatory Rheumatism (2007)
Biotechnology facts and figures
<p class="MsoBodyText2" style="line-height: normal;"><span lang="EN-GB" style="font-size: 10pt; font-family: Arial;"><strong>Biotechnologies are a strategic sector</strong> – from both an economic and social point of view – on an international scale: biological products currently represent 40% of the total registered products and if we take into account chemical medicines developed with biotechnologies, <strong>we can estimated than over 50% of the new medicines originate from them, notably the most innovative medicines</strong> (insulin, growth hormones, recombinant growth factors, vaccinations, monoclonal antibodies for the treatment of cancers, inflammatory and infectious diseases, cell therapy, etc) and <strong>almost 250 million patients worldwide</strong> are already benefiting from advances made in biotechnologies, both in diagnostics and in treatment. </span></p> <p class="MsoBodyText2" style="line-height: normal;"><span lang="EN-GB" style="font-size: 10pt; font-family: Arial;">Small and medium-sized biotechnology firms <strong>(3,500 worldwide, approximately 250 to <st1:metricconverter productid="300 in" w:st="on">300 in</st1:metricconverter> <st1:place w:st="on"><st1:country-region w:st="on">France</st1:country-region></st1:place>)</strong> together with researchers are renewing the pipeline of the therapeutic products available to doctors and patients, undertaking cutting-edge research and using the very latest technologies.</span></p> <p class="MsoBodyText2" style="line-height: normal;"><span lang="EN-GB" style="font-size: 10pt; font-family: Arial;"> The fields of application of biotechnologies are extremely varied, and b<strong>eyond human or animal health</strong>, biotechnology firms are also developing innovative applications in <strong>various industrial fields, in environmental protection and in agri-business, in particular.</strong><o:p></o:p></span></p>
